NumerixS Investment Technologies’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

NumerixS Investment Technologies’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,488	Closed	-$101K	–	1397
2018 Q1	$101K	Buy	1,488 +1,299	+687%	+$92K	0.02%	655
2017 Q4	$14K	Buy	+189	New	+$15.6K	﹤0.01%	1035
2015 Q3	–	Sell	-933	Closed	-$372K	–	810
2015 Q2	$372K	Buy	+933	New	+$396K	0.05%	451

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NumerixS Investment Technologies's LUMO Position: Q2 2018 in Review

NumerixS Investment Technologies sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 1,488 shares — an estimated $101K sold.

NumerixS Investment Technologies first reported a position in LUMO in Q2 2015 and held it in 3 quarters. The position peaked at $372K in Q2 2015. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

NumerixS Investment Technologies reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
NumerixS Investment Technologies sold 1,488 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $101K.
NumerixS Investment Technologies first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 3 quarters.
NumerixS Investment Technologies's Lumos Pharma, Inc. Common Stock position peaked at $372K in Q2 2015.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on NumerixS Investment Technologies's 13F filing for Q2 2018, filed 10 Aug 2018.